|Time-and passage-dependent characteristics of a Calu-3 respiratory epithelial cell model|
M Haghi, PM Young, D Traini, R Jaiswal, J Gong, M Bebawy
Drug development and industrial pharmacy 36 (10), 1207-1214, 2010
|Across the pulmonary epithelial barrier: Integration of physicochemical properties and human cell models to study pulmonary drug formulations|
M Haghi, HX Ong, D Traini, P Young
Pharmacology & therapeutics 144 (3), 235-252, 2014
|Deposition, diffusion and transport mechanism of dry powder microparticulate salbutamol, at the respiratory epithelia|
M Haghi, D Traini, M Bebawy, PM Young
Molecular pharmaceutics 9 (6), 1717-1726, 2012
|Quercetin solid lipid microparticles: a flavonoid for inhalation lung delivery|
S Scalia, M Haghi, V Losi, V Trotta, PM Young, D Traini
European Journal of Pharmaceutical Sciences 49 (2), 278-285, 2013
|Autophagy activation in asthma airways remodeling|
KD McAlinden, DA Deshpande, S Ghavami, D Xenaki, SS Sohal, ...
American journal of respiratory cell and molecular biology 60 (5), 541-553, 2019
|In vitro cell integrated impactor deposition methodology for the study of aerodynamically relevant size fractions from commercial pressurised metered dose inhalers|
M Haghi, D Traini, P Young
Pharmaceutical research 31 (7), 1779-1787, 2014
|In vitro biological activity of resveratrol using a novel inhalable resveratrol spray-dried formulation|
V Trotta, WH Lee, CY Loo, M Haghi, PM Young, S Scalia, D Traini
International journal of pharmaceutics 491 (1-2), 190-197, 2015
|Development of an inhaled controlled release voriconazole dry powder formulation for the treatment of respiratory fungal infection|
S Arora, M Haghi, CY Loo, D Traini, PM Young, S Jain
Molecular pharmaceutics 12 (6), 2001-2009, 2015
|Fluticasone uptake across Calu‐3 cells is mediated by salmeterol when deposited as a combination powder inhaler|
M Haghi, D Traini, DS Postma, M Bebawy, PM Young
Respirology 18 (8), 1197-1201, 2013
|Towards the bioequivalence of pressurised metered dose inhalers 1: design and characterisation of aerodynamically equivalent beclomethasone dipropionate inhalers with andá…|
DA Lewis, PM Young, F Buttini, T Church, P Colombo, B Forbes, M Haghi, ...
European Journal of Pharmaceutics and Biopharmaceutics 86 (1), 31-37, 2014
|Profiling of healthy and asthmatic airway smooth muscle cells following interleukin-1β treatment: a novel role for CCL20 in chronic mucus hypersecretion|
A Faiz, M Weckmann, H Tasena, CJ Vermeulen, M Van den Berge, ...
European Respiratory Journal 52 (2), 1800310, 2018
|Multiple dosing of simvastatin inhibits airway mucus production of epithelial cells: implications in the treatment of chronic obstructive airway pathologies|
L Marin, D Traini, M Bebawy, P Colombo, F Buttini, M Haghi, HX Ong, ...
European Journal of Pharmaceutics and Biopharmaceutics 84 (3), 566-572, 2013
|Highly respirable dry powder inhalable formulation of voriconazole with enhanced pulmonary bioavailability|
S Arora, M Haghi, PM Young, M Kappl, D Traini, S Jain
Expert opinion on drug delivery 13 (2), 183-193, 2016
|Towards the bioequivalence of pressurised metered dose inhalers 2. Aerodynamically equivalent particles (with and without glycerol) exhibit different biopharmaceutical profilesá…|
M Haghi, M Bebawy, P Colombo, B Forbes, DA Lewis, R Salama, D Traini, ...
European Journal of Pharmaceutics and Biopharmaceutics 86 (1), 38-45, 2014
|The formulation of a pressurized metered dose inhaler containing theophylline for inhalation|
B Zhu, M Haghi, M Goud, PM Young, D Traini
European Journal of Pharmaceutical Sciences 76, 68-72, 2015
|Salbutamol sulfate absorption across Calu-3 bronchial epithelia cell monolayer is inhibited in the presence of common anionic NSAIDs|
M Mamlouk, PM Young, M Bebawy, M Haghi, S Mamlouk, V Mulay, ...
Journal of Asthma 50 (4), 334-341, 2013
|A ‘soft spot’for drug transport: modulation of cell stiffness using fatty acids and its impact on drug transport in lung model|
M Haghi, D Traini, LG Wood, B Oliver, PM Young, W Chrzanowski
Journal of Materials Chemistry B 3 (13), 2583-2589, 2015
|Delivery of theophylline as dry powder for inhalation|
B Zhu, M Haghi, A Nguyen, M Goud, S Yeung, PM Young, D Traini
asian journal of pharmaceutical sciences 10 (6), 520-527, 2015
|Inhalable tranexamic acid for haemoptysis treatment|
M Haghi, W van den Oetelaar, LM Moir, B Zhu, G Phillips, J Crapper, ...
European Journal of Pharmaceutics and Biopharmaceutics 93, 311-319, 2015
|Mono-and cocultures of bronchial and alveolar epithelial cells respond differently to proinflammatory stimuli and their modulation by salbutamol and budesonide|
M Haghi, M Hittinger, Q Zeng, B Oliver, D Traini, PM Young, H Huwer, ...
Molecular Pharmaceutics 12 (8), 2625-2632, 2015